IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells

Hironaka, 2003, Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3) N(any) M(0) squamous cell carcinoma of the esophagus, Int. J. Radiat. Oncol., 57, 425, 10.1016/S0360-3016(03)00585-6 Ishikura, 2003, Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus, J. Clin. Oncol., 21, 2697, 10.1200/JCO.2003.03.055 Nishihira, 1993, Molecular and cellular features of esophageal cancer cells, J. Cancer Res. Clin. Oncol., 119, 441, 10.1007/BF01215923 Baxter, 2000, Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3, Growth Horm. IGF Res., 10, S10, 10.1016/S1096-6374(00)90004-2 Oh, 1993, Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition, J. Biol. Chem., 268, 14964, 10.1016/S0021-9258(18)82426-7 Rajah, 1997, Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism, J. Biol. Chem., 272, 12181, 10.1074/jbc.272.18.12181 Butt, 2001, IGFBP-3 and apoptosis–a license to kill?, Apoptosis, 6, 199, 10.1023/A:1011388710719 Gill, 1997, Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGFdependent manner, J. Biol. Chem., 272, 25602, 10.1074/jbc.272.41.25602 Williams, 2000, Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells, Cancer Res., 60, 22 Hollowood, 2000, IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation, Int. J. Cancer, 88, 336, 10.1002/1097-0215(20001101)88:3<336::AID-IJC3>3.0.CO;2-A Collard, 2003, Transcriptional up-regulation of the insulin–like growth factor binding proteinIGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma derived epithelial cells, Carcinogenesis, 24, 393, 10.1093/carcin/24.3.393 Butt, 2000, Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells, J. Biol. Chem., 275, 39174, 10.1074/jbc.M908888199 Torng, 2008, Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma, Oncogene, 27, 2137, 10.1038/sj.onc.1210864 Torng, 2009, Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma, Mol. Cancer, 8, 120, 10.1186/1476-4598-8-120 Chang, 2002, Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer, Clin. Cancer Res., 8, 3669 Hanafusa, 2002, Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma, Cancer Lett., 176, 149, 10.1016/S0304-3835(01)00736-4 Wiley, 2006, Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer, Int. J. Gynecol. Cancer, 16, 210, 10.1111/j.1525-1438.2006.00299.x Tomii, 2007, Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers, Int. J. Cancer, 120, 566, 10.1002/ijc.22341 Aishima, 2006, High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma, Caner Sci., 97, 1182, 10.1111/j.1349-7006.2006.00322.x Takayama, 1995, Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity, Cell, 80, 279, 10.1016/0092-8674(95)90410-7 Townsend, 2003, BAG-1: a multifunctional regulator of cell growth and survival Review Article, Biochim. Biophys. Acta, 1603, 83 Turner, 2001, BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer, J. Clin. Oncol., 19, 992, 10.1200/JCO.2001.19.4.992 Rorke, 2001, Prognostic significance of BAG-1 expression in nonsmall cell lung cancer, Int. J. Cancer, 95, 317, 10.1002/1097-0215(20010920)95:5<317::AID-IJC1055>3.0.CO;2-J Shindoh, 2000, BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma, Oral Oncol., 36, 444, 10.1016/S1368-8375(00)00025-7 Yamauchi, 2001, Nuclear BAG-1 localization and the risk of recurrence after radiation therapy in laryngeal carcinomas, Cancer Lett., 165, 103, 10.1016/S0304-3835(01)00397-4 Yawata, 1998, Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells, Oncogene, 16, 2681, 10.1038/sj.onc.1201792 Bai, 2007, Clinicopathologic significance of BAG1 and TIMP3 expression in colon carcinoma, World J. gastroentero., 13, 3883, 10.3748/wjg.v13.i28.3883 Clemo, 2008, BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-κB activity, Carcinogenesis, 29, 849, 10.1093/carcin/bgn004 Takaoka, 1997, Anti-cell death activity promotes pulmonary metastasis of melanoma cells, Oncogene, 14, 2971, 10.1038/sj.onc.1201147 Roth, 2000, Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis, Brain Pathol., 10, 223, 10.1111/j.1750-3639.2000.tb00256.x Yang, 2000, BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)-retinamide in human cervical carcinoma cells, Exp. Cell Res., 256, 491, 10.1006/excr.2000.4829 Townsend, 2005, BAG-1: a multi-functional pro-survival molecule, Int. J. Biochem. Cell Biol., 37, 251, 10.1016/j.biocel.2004.03.016 Ding, 2000, Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug resistant cells, Biochem. Biophys. Res. Commun., 270, 415, 10.1006/bbrc.2000.2432 Takayama, 2001, Molecular chaperone targeting and regulation by BAG family proteins, Nat. Cell Biol., 3, 237, 10.1038/ncb1001-e237 Okumura, 2005, The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma, Br. J. Surg., 92, 284 Barnas, 1997, Inactivation of the p53 protein in cell lines derived from human esophageal cancers, Int. J. Cancer, 71, 79, 10.1002/(SICI)1097-0215(19970328)71:1<79::AID-IJC14>3.0.CO;2-4 Hayashi, 2008, REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cell, Cancer Sci., 99, 2491, 10.1111/j.1349-7006.2008.00980.x Motoyama, 2006, REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patient treated with neoadjuvant chemoradiotherapy followed by esophagectomy, Ann. Surg. Oncol., 13, 1724, 10.1245/s10434-006-9075-z Hayashi, 2008, REG Iα is a Reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients, Ann. Surg. Oncol., 15, 1224, 10.1245/s10434-008-9810-8 Trent, 2007, Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity, Cancer Res., 67, 10774, 10.1158/0008-5472.CAN-07-1475 Hsaio, 1997, Functional expression of human p21 (WAFI/CIPI) gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity, Biochem. Biophys. Res. Commun., 233, 329, 10.1006/bbrc.1997.6450 Matsumura, 1997, Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene, Cancer Lett., 115, 91, 10.1016/S0304-3835(97)04714-9 Sklar, 1988, The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation, Science, 239, 645, 10.1126/science.3277276 Kasid, 1987, The raf oncogene is associated with a radiation-resistant human laryngeal cancer, Science, 237, 1039, 10.1126/science.3616625 Kastan, 2004, Cell-cycle checkpoints and cancer, Nature, 432, 316, 10.1038/nature03097